0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Contribution |  November 14, 2012 FREE
Multivitamins in the Prevention of Cancer in Men:  The Physicians' Health Study II Randomized Controlled Trial
J. Michael Gaziano, MD, MPH; Howard D. Sesso, ScD, MPH; William G. Christen, ScD; et al.
JAMA. 2012;308(18):1871-1880. doi:10.1001/jama.2012.14641.
INCLUDES: CME , Supplemental Content
Medical News and Perspectives |  August 01, 2012
New Research Reveals Positive Therapies and Methods for Treating Prostate Cancer
Mike Mitka
JAMA. 2012;308(5):441-442. doi:10.1001/jama.2012.7960.
Research Letters |  April 25, 2012 FREE
2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates
Sandip M. Prasad, MD, MPhil; Michael W. Drazer, BA; Dezheng Huo, MD, PhD; et al.
JAMA. 2012;307(16):1692-1694. doi:10.1001/jama.2012.534.
Original Contribution |  April 18, 2012 FREE
Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer
Nathan C. Sheets, MD; Gregg H. Goldin, MD; Anne-Marie Meyer, PhD; et al.
JAMA. 2012;307(15):1611-1620. doi:10.1001/jama.2012.460.
INCLUDES: , Supplemental Content
Viewpoint |  February 08, 2012
The Harms of Screening:  New Attention to an Old Concern
Steven H. Woolf, MD, MPH; Russell Harris, MD, MPH
JAMA. 2012;307(6):565-566. doi:10.1001/jama.2012.100.
Medical News and Perspectives |  January 11, 2012
Expert Panel Advocates Surveillance for Men With Low-Risk Prostate Cancer
Anita Slomski
JAMA. 2012;307(2):133. doi:10.1001/jama.2011.1965.
Commentary |  December 28, 2011
Prostate Cancer Screening—Time to Abandon One-Size-Fits-All Approach?
Jeri Kim, MD; John W. Davis, MD
JAMA. 2011;306(24):2717-2718. doi:10.1001/jama.2011.1881.
Commentary |  December 28, 2011
Missing the Mark on Prostate-Specific Antigen Screening
David C. Miller, MD, MPH; Brent K. Hollenbeck, MD, MS
JAMA. 2011;306(24):2719-2720. doi:10.1001/jama.2011.1879.
Commentary |  December 28, 2011
Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation
Robert J. Volk, PhD; Andrew M. D. Wolf, MD
JAMA. 2011;306(24):2715-2716. doi:10.1001/jama.2011.1893.
Commentary |  December 28, 2011
Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications
Roger Chou, MD; Michael L. LeFevre, MD, MSPH
JAMA. 2011;306(24):2721-2722. doi:10.1001/jama.2011.1891.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  Mar 11, 2013
Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening:  A Randomized Controlled Trial
Michael Patrick Pignone, MD, MPH; Kirsten Howard, PhD, MPH; Alison Tytell Brenner, MPH; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned
Giuseppe Lippi, MD; Camilla Mattiuzzi, MD; Gianfranco Cervellin, MD
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate Cancer Screening and Incidence: A Question of Causality
Jesse David Sammon, DO; Shyam Sukumar, MD; Quoc-Dien Trinh, MD, FRCSC
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate Cancer Screening and Incidence: A Question of Causality—Reply
David H. Howard, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems